Abstract
163. Improvements in CAR-Based Immunotherapy Combining Immunomodulatory Doses of Lenalidomide for the Treatment of Chronic Lymphocytic Leukemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have